Product Images Nabumetone

This is a chart that shows the plasma concentrations of the nabumetone active metabolite (BMNA) at steady state, following once-daily dosing of either 1000 mg or 2000 mg of nabumetone. There were 31 participants in the 1000 mg group and 12 participants in the 2000 mg group. The chart shows the concentration levels over time, ranging from 0 to 24 hours.*

Each tablet contains 500mg of Nabumetone, which is a USP medication. The usual dosage is not available, but prescribing information is available with the item. The tablets should be stored at a temperature ranging from 20°C to 25°C (68°F to 77°F). Excursions from this temperature range are permitted up to 15°C to 30°C (59°F to 86°F). The product should be dispensed in a tightly sealed and light-resistant container. The medication guide must be provided to each patient. The product is manufactured by ScieGen Pharmaceuticals Inc. and distributed by Westminster Pharmaceuticals LLC. This product is available in a bottle containing 500 tablets.*

Each tablet of this medication contains 750 mg of Nabumetone, USP. It is recommended to store it at 20° to 25°C (68°F to 77°%), excursions permitted 1 15°C 0 30°C (59°F to 86°F) in a tight, light-resistant container with a child-resistant closure. This medication should be kept out of reach of children. It comes with an accompanying medication guide to be dispensed to each patient. Manufactured by ScieGen Pharmaceuticals, Inc. for Westminster Pharmaceuticals, LLC. This bottle contains 500 tablets.*